Literature DB >> 8825122

The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

C L Arteaga1, T C Dugger, S D Hurd.   

Abstract

The transforming growth factor-beta s are potent growth inhibitors of normal and transformed breast epithelial cells in culture. In vivo, these peptides modulate the development of the mouse mammary gland. Tissue-specific overexpression of mature TGF-beta 1 in transgenic mice results in mammary gland atrophy and prevention of carcinogen-induced breast tumorigenesis. However, the inhibitory effect of endogenous or exogenous TGF-beta s on established tumor cells is less clear. Several published circumstantial and more direct data argue that, in some cases, the tumor cell TGF-beta s may contribute to the maintenance and/or progression of tumor cells in an intact host by modulating their interaction with host factors. This differential role of the TGF-beta s on mammary cells as determined by their normal or transformed phenotype as well as the biological and clinical implications of these data are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825122     DOI: 10.1007/bf01803783

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  48 in total

1.  Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells.

Authors:  R J Daly; R J King; P D Darbre
Journal:  J Cell Biochem       Date:  1990-07       Impact factor: 4.429

2.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

Authors:  G Zugmaier; B W Ennis; B Deschauer; D Katz; C Knabbe; G Wilding; P Daly; M E Lippman; R B Dickson
Journal:  J Cell Physiol       Date:  1989-11       Impact factor: 6.384

4.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

Authors:  B A Arrick; M Korc; R Derynck
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

5.  Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.

Authors:  A M Wärri; R L Huovinen; A M Laine; P M Martikainen; P L Härkönen
Journal:  J Natl Cancer Inst       Date:  1993-09-01       Impact factor: 13.506

6.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Authors:  S M Gorsch; V A Memoli; T A Stukel; L I Gold; B A Arrick
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

7.  TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization.

Authors:  C W Daniel; G B Silberstein; K Van Horn; P Strickland; S Robinson
Journal:  Dev Biol       Date:  1989-09       Impact factor: 3.582

8.  Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland.

Authors:  G B Silberstein; P Strickland; S Coleman; C W Daniel
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

9.  Transcripts for transforming growth factors in human breast cancer: clinical correlates.

Authors:  P Barrett-Lee; M Travers; Y Luqmani; R C Coombes
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

10.  Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.

Authors:  R A Walker; S J Dearing; B Gallacher
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  9 in total

Review 1.  Epigenetic changes accompanying human mammary epithelial cell immortalization.

Authors:  P Yaswen; M R Stampfer
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 2.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 3.  Growth factors, apoptosis, and survival of mammary epithelial cells.

Authors:  E C Rosfjord; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

4.  Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells.

Authors:  M R Stampfer; A Bodnar; J Garbe; M Wong; A Pan; B Villeponteau; P Yaswen
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

Review 5.  Heme oxygenase-1 as a target for TGF-β in kidney disease.

Authors:  Abolfazl Zarjou; Anupam Agarwal
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

6.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

Authors:  J J Yin; K Selander; J M Chirgwin; M Dallas; B G Grubbs; R Wieser; J Massagué; G R Mundy; T A Guise
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 7.  Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.

Authors:  M Kretzschmar
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

8.  Upregulation of maspin expression in human cervical carcinoma cells by transforming growth factor β1 through the convergence of Smad and non-Smad signaling pathways.

Authors:  Ariyaphong Wongnoppavich; Nahathai Dukaew; Sirinthip Choonate; Kongthawat Chairatvit
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

9.  Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer.

Authors:  Prajjal K Singha; Srilakshmi Pandeswara; Hui Geng; Rongpei Lan; Manjeri A Venkatachalam; Albert Dobi; Shiv Srivastava; Pothana Saikumar
Journal:  Genes Cancer       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.